Any transition to NASDAQ had better be a follow to heavy external IR presence at conferences, roadshows, etc to get the name out. Otherwise, Elite will get indexes to buy in, larger short term funds that will trade, but no long term fund ownership. Would be nice to see sell-side coverage started if they can get a couple larger drugs approved and launched. Long term holders are needed to provide share price stability.